These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34324844)

  • 1. Two novel mutations of the LPL gene in two Chinese family cases with familial chylomicronemia syndrome.
    Wang M; Zhou Y; He X; Deng C; Liu X; Li J; Zhou L; Li Y; Zhang Y; Liu H; Li L
    Clin Chim Acta; 2021 Oct; 521():264-271. PubMed ID: 34324844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial chylomicronemia syndrome caused by compound heterozygous mutation of lipoprotein lipase gene: A case report and review of literature.
    Huang Y; Qin Y; Liao L; Lin F
    Clin Chim Acta; 2022 Dec; 537():112-117. PubMed ID: 36252692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
    Ariza MJ; Rioja J; Ibarretxe D; Camacho A; Díaz-Díaz JL; Mangas A; Carbayo-Herencia JA; Ruiz-Ocaña P; Lamíquiz-Moneo I; Mosquera D; Sáenz P; Masana L; Muñiz-Grijalvo O; Pérez-Calahorra S; Valdivielso P;
    J Clin Lipidol; 2018; 12(6):1482-1492.e3. PubMed ID: 30150141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
    Caddeo A; Mancina RM; Pirazzi C; Russo C; Sasidharan K; Sandstedt J; Maurotti S; Montalcini T; Pujia A; Leren TP; Romeo S; Pingitore P
    Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):158-164. PubMed ID: 29288010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
    Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
    J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional characterization of familial chylomicronemia syndrome.
    Teramoto R; Tada H; Kawashiri MA; Nohara A; Nakahashi T; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2018 Feb; 269():272-278. PubMed ID: 29153744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
    Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
    J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase.
    Al-Shali K; Wang J; Fellows F; Huff MW; Wolfe BM; Hegele RA
    Clin Biochem; 2002 Mar; 35(2):125-30. PubMed ID: 11983347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound heterozygosity for a new (S259G) and a previously described (G188E) mutation in lipoprotein lipase (LpL) as a cause of chylomicronemia. Mutations in brief no. 183. Online.
    Evans D; Wendt D; Ahle S; Guerra A; Beisiegel U
    Hum Mutat; 1998; 12(3):217. PubMed ID: 10660334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel missense mutation in the gene for lipoprotein lipase resulting in a highly conservative amino acid substitution (Asp180-->Glu) causes familial chylomicronemia (type I hyperlipoproteinemia).
    Haubenwallner S; Hörl G; Shachter NS; Presta E; Fried SK; Höfler G; Kostner GM; Breslow JL; Zechner R
    Genomics; 1993 Nov; 18(2):392-6. PubMed ID: 8288243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene.
    Rabacchi C; D'Addato S; Palmisano S; Lucchi T; Bertolini S; Calandra S; Tarugi P
    J Clin Lipidol; 2016; 10(4):915-921.e4. PubMed ID: 27578123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome.
    Rioja J; Ariza MJ; Benítez-Toledo MJ; Espíldora-Hernández J; Coca-Prieto I; Arrobas-Velilla T; Camacho A; Olivecrona G; Sánchez-Chaparro MÁ; Valdivielso P
    J Clin Lipidol; 2023; 17(2):272-280. PubMed ID: 36813655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.
    Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ
    BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Characterization of Two Novel Compounds: Heterozygous Variants of
    Wang S; Cheng Y; Shi Y; Zhao W; Gao L; Fang L; Jin X; Han X; Sun Q; Li G; Zhao J; Xu C
    Front Endocrinol (Lausanne); 2022; 13():874608. PubMed ID: 35923617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene.
    Ameis D; Kobayashi J; Davis RC; Ben-Zeev O; Malloy MJ; Kane JP; Lee G; Wong H; Havel RJ; Schotz MC
    J Clin Invest; 1991 Apr; 87(4):1165-70. PubMed ID: 2010533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.
    Wilson DE; Hata A; Kwong LK; Lingam A; Shuhua J; Ridinger DN; Yeager C; Kaltenborn KC; Iverius PH; Lalouel JM
    J Clin Invest; 1993 Jul; 92(1):203-11. PubMed ID: 8325986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency.
    Rodrigues R; Artieda M; Tejedor D; Martínez A; Konstantinova P; Petry H; Meyer C; Corzo D; Sundgreen C; Klor HU; Gouni-Berthold I; Westphal S; Steinhagen-Thiessen E; Julius U; Winkler K; Stroes E; Vogt A; Hardt P; Prophet H; Otte B; Nordestgaard BG; Deeb SS; Brunzell JD
    J Clin Lipidol; 2016; 10(2):394-409. PubMed ID: 27055971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hypertriglyceridemia due to two novel loss-of-function lipoprotein lipase gene mutations (C310R/E396V) in a Chinese family associated with recurrent acute pancreatitis.
    Lun Y; Sun X; Wang P; Chi J; Hou X; Wang Y
    Oncotarget; 2017 Jul; 8(29):47741-47754. PubMed ID: 28548960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missense mutation Leu72Pro located on the carboxyl terminal amphipathic helix of apolipoprotein C-II causes familial chylomicronemia syndrome.
    Lam CW; Yuen YP; Cheng WF; Chan YW; Tong SF
    Clin Chim Acta; 2006 Feb; 364(1-2):256-9. PubMed ID: 16153625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single Ser259Arg mutation in the gene for lipoprotein lipase causes chylomicronemia in Moroccans of Berber ancestry.
    Foubert L; Bruin T; De Gennes JL; Ehrenborg E; Furioli J; Kastelein J; Benlian P; Hayden M
    Hum Mutat; 1997; 10(3):179-85. PubMed ID: 9298816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.